Cardiovascular Disease Early Detection and Prevention Act of 2026
Sponsored By: Representative Cherfilus-McCormick
Introduced
Summary
This bill would require no-cost coverage of lipoprotein(a) (Lp(a)) and apolipoprotein B (ApoB) testing for people at elevated cardiovascular risk. It aims to widen detection of hidden lipid risks that routine panels often miss and improve prevention of heart attacks and strokes.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Free Lp(a) and ApoB tests for eligible people
If enacted, private group and individual health plans, Medicare, and Medicaid would be required to cover tests for lipoprotein(a) and apolipoprotein B without cost sharing for eligible people. You would get these tests with no out-of-pocket cost if you have a family history of early heart disease, a past heart attack or stroke, high LDL cholesterol, diabetes, obesity, or other recognized heart-risk factors. For private plans this would apply to plan years beginning 180 days after enactment. For Medicare and Medicaid the rule would apply to tests furnished on or after that same date.
Sponsors & CoSponsors
Sponsor
Cherfilus-McCormick
FL • D
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov